Sign in

CIK 0001830487

  • Large accelerated filer

Pharvaris N.V.

Sign in to watch
Ticker
PHVS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Netherlands
Entity type
Other
Phone
+31 712036410
Business address
J.H. OORTWEG 21, 2333 CH LEIDEN, LEIDEN, Netherlands
Former names
Pharvaris, B.V.
  1. 4 Open-market sale Director sold 10,000 shares at an average $29.82 ($298,245)
  2. 4 Open-market sale Chief Technical Ops Officer sold 8,748 shares at $29.82 ($260,864)
  3. 4 Planned sale Chief Commercial Officer sold 10,000 shares at $29.92 ($299,163)
  4. 4 Shares withheld for taxes Chief Medical Officer gave up 226 shares (to pay taxes)
  5. 4 Planned sale Chief Medical Officer sold 14,166 shares at an average $30.17 ($427,419)
  6. 4 Planned sale Director sold 32,900 shares at an average $30.29 ($996,545)
  7. 4 Planned sale Chief Early Development sold 48,300 shares at an average $30.23 ($1,459,970)
  8. 4 Planned sale Chief Medical Officer sold 18,733 shares at an average $30.21 ($565,859)
  9. 4 Planned sale Director sold 7,100 shares at an average $30.05 ($213,382)
  10. 4 Planned sale Chief Early Development sold 14,700 shares at an average $30.05 ($441,726)
  11. 4 Planned sale Chief Medical Officer sold 7,101 shares at an average $30.05 ($213,405)
  12. 4 Shares withheld for taxes Chief Medical Officer gave up 226 shares (to pay taxes)
  13. 4 Planned sale Chief Executive Officer sold 2,292 shares at $28.60 ($65,559)
  14. 4 Shares withheld for taxes Principal Accounting Officer gave up 548 shares (to pay taxes)
  15. 4 Planned sale Chief Executive Officer sold 23,333 shares at an average $27.74 ($647,281)
  16. 4 Shares withheld for taxes Principal Accounting Officer gave up 1,167 shares (to pay taxes)
  17. 4 Shares withheld for taxes Principal Accounting Officer gave up 1,164 shares (to pay taxes)
  18. 3/A Insider 3/A
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 3 of 4 · 71 filings